Hartford Investment Management Co (HIMCO)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CB
VBA
BTW
Hartford Investment Management Co (HIMCO)'s CRL Position: Q2 2026 in Review
Hartford Investment Management Co (HIMCO) reduced its Charles River Laboratories (CRL) stake by 7% in Q2 2026, selling an estimated $35.3K and leaving 2,638 shares worth $598K. The position accounts for 0.02% of the portfolio, ranked #461.
Hartford Investment Management Co (HIMCO) first reported a position in CRL in Q2 2018 and has held it in 24 quarters since. The position peaked at $1.98M in Q2 2021. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Hartford Investment Management Co (HIMCO) held 2,638 shares of Charles River Laboratories worth $598K as of Q2 2026.
- Hartford Investment Management Co (HIMCO) sold 198 Charles River Laboratories shares in Q2 2026, an estimated $35.3K.
- Charles River Laboratories made up 0.02% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #461 holding.
- Hartford Investment Management Co (HIMCO) first reported a position in Charles River Laboratories in Q2 2018 and has held it in 24 quarters since.
- Hartford Investment Management Co (HIMCO)'s Charles River Laboratories position peaked at $1.98M in Q2 2021.
- 260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.